Product Information
ZYPITAMAG 2 MG TABLET is a brand product labeled by Medicure International Inc, priced at $7.4261 per EA under NDC 25208020115. Its NADAC has been published 129 times since Apr 17, 2024.
FDA first approved this application on Jul 14, 2017.
Strength
2 mg/1
Manufacturer
Medicure International IncNDC
25208020115
Classification
Brand
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
PITAVASTATINApproval Type
New Drug (NDA)
FDA Application
NDA208379FDA Approved
7/14/2017
On Market Since
3/9/2018
Pharmacological Classes
Price Statistics
The NADAC for ZYPITAMAG 2 MG TABLET has been published 129 times since Apr 17, 2024, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $7.4261 per EA |
|---|---|
| All-time high | $7.4684 (Jun 12, 2024) |
| All-time low | $7.4261 (Sep 23, 2026) |
| 52-week high | $7.4501 |
| 52-week low | $7.4261 |
| Median price | $7.4378 |
| Average price | $7.4405 |
| Largest weekly change | +0.4% (May 22, 2024) |
| Weeks tracked | 129 |
| Tracking since | Apr 17, 2024 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Medicure International Inc manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Pitavastatin Magnesium market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
HMG-CoA Reductase Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ZYPITAMAG 2 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ZYPITAMAG 2 MG TABLET, manufactured by Medicure International Inc, is $7.4261 per EA (NDC 25208020115), effective Sep 30, 2026.
How has the price of ZYPITAMAG 2 MG TABLET changed over time?
Over the history we have for it, the NADAC for ZYPITAMAG 2 MG TABLET has held within roughly two percent of its current level. It has been tracked across 129 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for ZYPITAMAG 2 MG TABLET?
Since Apr 17, 2024, the NADAC for ZYPITAMAG 2 MG TABLET has ranged from a low of $7.4261 (Sep 23, 2026) to a high of $7.4684 (Jun 12, 2024), with a median of $7.4378 per EA.
Are there cheaper alternatives to ZYPITAMAG 2 MG TABLET?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as ZYPITAMAG 2 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures ZYPITAMAG 2 MG TABLET?
ZYPITAMAG 2 MG TABLET (NDC 25208020115) is labeled by Medicure International Inc, and CMS classifies it as a brand product.